XML 56 R37.htm IDEA: XBRL DOCUMENT
v3.25.0.1

STOCK-BASED COMPENSATION (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2024
Share-Based Payment Arrangement [Abstract] |
Total Stock-Based Compensation Expense | Total stock-based compensation expense in our Consolidated Statements of Income during the twelve months ended December 31, 2024, 2023 and 2022 was as follows:
|  | Twelve Months Ended December 31,
|  | 2024 |  | 2023 |  | 2022
|  | (In millions)
Cost of services |  | $ | 13.4 |  |  | $ | 14.5 |  |  | $ | 12.4 |
Selling, general and administrative expenses |  | 68.2 |  |  | 57.3 |  |  | 50.2 |
Stock-based compensation expense, before income taxes |  | $ | 81.6 |  |  | $ | 71.8 |  |  | $ | 62.6 |
Assumptions Used to Estimate Fair Value of Stock Options Granted | The fair value for stock options granted during the twelve months ended December 31, 2024, 2023 and 2022 was estimated at the date of grant using the binomial model with the following weighted-average assumptions:
| Twelve Months Ended December 31,
| 2024 |  | 2023 |  | 2022
Dividend yield | 0.8 | % |  | 0.8 | % |  | 0.7 | %
Expected volatility | 31.9 | % |  | 33.1 | % |  | 31.5 | %
Risk-free interest rate | 4.1 | % |  | 3.9 | % |  | 2.4 | %
Expected term (in years) | 4.8 |  | 4.8 |  | 5.0
Weighted-average fair value of stock options granted | $ | 75.97 |  | $ | 63.70 |  | $ | 59.70
Changes in Outstanding Options and Weighed-Average Exercise Price Per Share | The following table summarizes changes in outstanding stock options during the twelve months ended December 31, 2024, as well as stock options that are vested and expected to vest and stock options exercisable at December 31, 2024:
| Shares |  | Weighted-Average Exercise Price |  | Weighted-Average Remaining Contractual Term |  | Aggregate Intrinsic Value
| (In thousands) |  |  |  | (In years) |  | (In millions)
Outstanding at December 31, 2023 | 1,961 |  |  | $ | 171.93 |  |  |  |  |
Granted (all at market price) | 233 |  |  | $ | 253.10 |  |  |  |  |
Exercised | (665) |  |  | $ | 151.56 |  |  |  |  |
Forfeited and canceled | (132) |  |  | $ | 183.23 |  |  |  |  |
Outstanding at December 31, 2024 | 1,397 |  |  | $ | 194.36 |  |  | 5.2 |  | $ | 85.8 |
Vested and expected to vest at December 31, 2024 | 1,386 |  |  | $ | 194.01 |  |  | 5.2 |  | $ | 85.6 |
Exercisable at December 31, 2024 | 776 |  |  | $ | 162.29 |  |  | 3.9 |  | $ | 71.9 |
The following table summarizes changes in outstanding options and the related weighted-average exercise price per share for the twelve months ended December 31, 2023 and 2022:
| December 31,
| 2023 |  | 2022
| Shares |  | Weighted- Average Exercise Price |  | Shares |  | Weighted- Average Exercise Price
| (In thousands) |  |  |  | (In thousands) |  |
Outstanding at the beginning of the year | 1,964 |  |  | $ | 164.72 |  |  | 1,710 |  |  | $ | 149.67 |
Granted (all at market price) | 259 |  |  | $ | 210.37 |  |  | 369 |  |  | $ | 232.28 |
Exercised | (218) |  |  | $ | 143.98 |  |  | (76) |  |  | $ | 136.84 |
Forfeited and canceled | (44) |  |  | $ | 205.81 |  |  | (39) |  |  | $ | 198.34 |
Outstanding at the end of the year | 1,961 |  |  | $ | 171.93 |  |  | 1,964 |  |  | $ | 164.72 |
Exercisable at end of year | 1,326 |  |  | $ | 150.58 |  |  | 1,268 |  |  | $ | 141.40 |
Summary of Changes in Nonvested Stock and Weighted-Average Grant Date Fair Value | The following table summarizes changes in these other stock awards during the twelve months ended December 31, 2024, 2023 and 2022 and the related weighted-average grant date fair value:
| Shares |  | Weighted-Average Grant Date Fair Value
| (In thousands) |  |
Nonvested at December 31, 2021 | 779 |  |  | $ | 159.73 |
Granted | 483 |  |  | $ | 196.97 |
Vested | (406) |  |  | $ | 133.26 |
Forfeited | (72) |  |  | $ | 202.70 |
Nonvested at December 31, 2022 | 784 |  |  | $ | 192.47 |
Granted | 373 |  |  | $ | 205.98 |
Vested | (215) |  |  | $ | 172.62 |
Forfeited | (86) |  |  | $ | 194.11 |
Nonvested at December 31, 2023 | 856 |  |  | $ | 203.17 |
Granted | 334 |  |  | $ | 250.64 |
Vested | (231) |  |  | $ | 178.51 |
Forfeited | (88) |  |  | $ | 217.04 |
Nonvested at December 31, 2024 | 871 |  |  | $ | 226.50 |

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (h)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the changes in outstanding nonvested shares. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (d) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (e) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Subparagraph (f)(2) -Name Accounting Standards Codification -Paragraph 2 -Section 50 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration